Skip to main content
R. Coleman Lindsley, MD, Oncology, Boston, MA, Brigham and Women's Hospital

R. ColemanLindsleyMDPhD

Oncology Boston, MA

Hematologic Oncology

Instructor, Dana-Farber Cancer Institute

Dr. Lindsley is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lindsley's full profile

Already have an account?

Education & Training

  • Dana-Farber Cancer Institute / MGH Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2010
  • Washington University
    Washington UniversityClass of 2008, M.D., Ph.D.

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2022
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
    R. Coleman Lindsley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
    R. Coleman Lindsley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
    R. Coleman Lindsley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Hospital Affiliations